Close Navigation

ISS EVA Research Roundup: September 11th, 2025

Posted September 12, 2025 at 9:45 am

ISS EVA

Weekly Research

Names in the News: ORCL and CPB (report)

This week, we cover Oracle Corporation (ORCL, rated ‘Underweight’) and The Campbell’s Company (CPB, rated ‘Buy’). ORCL’s stock saw a 36% surge on Wednesday, posting its best trading day since 1992, after the firm reported $455B in contract backlog, a 359% increase from a year earlier. CPB, a High Quality and Cheap name, recently announced that the firm is planning to end the use of synthetic food dyes in its food or beverage products starting next year.

High Quality Today & Spending for Tomorrow (report)

In this report we screen for companies that are high Quality in the EVA framework that are investing heavily relative to their prior trend in Capex. These firms still have decent absolute Profitability (deep economic moat) today and are investing in the future.

Russell 2000 Value Index: Dissecting Value (report)

A few times each year, we re-visit the Russell 2000 Value and Growth Indexes to identify discrepancies between our view of value and growth and Russell’s. We provide a list of companies overweight in the Russell 2000 Value Index that score expensive in our Value factor and unattractive in PRVit, and a list of the most attractive and cheapest names in the index.

Russell 2000 Growth Index: Dissecting Growth (report)

Aggregate EVA Momentum for the Russell 2000 Index hit an all-time low of -2.9% in February 2024, and over the last 18 months the EVA Momentum has rebounded to -0.2%. As we have noted, when growth is scarce, buy growth; and while EVA Momentum has inflected up, it remains below most of the index’s history.

Construction & Engineering: EVA Fundamentals Inflecting Up (report)

The global Construction & Engineering industry continues to look attractive in the PRVit framework after seeing strong returns this year. Quality (P-R) is rated unfavorably for the global industry aggregate, but Value scores remain low (relatively cheap), making the industry look attractive overall.

Industry Snapshot: Global Personal Care Products (report)

EVA Profitability has contracted through 2025 so far, while EVA growth looks to have bottomed out in negative territory. Asset efficiency has improved, supported by top-line growth turning positive; however, EBITDAR Margin remains pressured. Large Cap firms, on average, look unattractive as strong Quality is offset by high Valuations. Investor expectations for value creation are trading around the upper end of the long-term range.

Industry Snapshot: Global Chemicals (report)

On average, Large Cap firms look unattractive in the PRVit model, as high Valuations outweigh strong Quality. EVA Margin has contracted to record lows, pressured by deteriorating asset efficiency and relatively weak EBTIDAR Margin. With EVA Momentum having seen a continued recovery over the last two years, investor expectations for incremental EVA creation going forward have turned very bullish.

Quant Reports

Factor Rotation: Select Regions/Countries (report)

Our Chart of the Week last week showed the performance of our Quality and Value factors. This week we provide similar graphs for key regions and countries. These plot the compound log returns of the factors for all companies in the region/country with a market cap over $1B.

Table of the Week

In this week’s ‘High Quality Today & Spending for Tomorrow’ report, we look at capex trends across the different sectors (ex-Financials & Real Estate) and screen for firms that are high Quality (P-R) and heavily investing for the future. What is noticeable is that eight of nine sectors are seeing an increase in spending in 2025, with only the Energy sector seeing a YoY decline in investment. Capex trends in IT are being driven by hyperscalers—Amazon (AWS), Microsoft (Azure), and Google (GCP)—but we are seeing a broad trend in increased spending across the sectors in PP&E and R&D investment.

Join The Conversation

For specific platform feedback and suggestions, please submit it directly to our team using these instructions.

If you have an account-specific question or concern, please reach out to Client Services.

We encourage you to look through our FAQs before posting. Your question may already be covered!

Leave a Reply

Disclosure: Interactive Brokers Third Party

Information posted on IBKR Campus that is provided by third-parties does NOT constitute a recommendation that you should contract for the services of that third party. Third-party participants who contribute to IBKR Campus are independent of Interactive Brokers and Interactive Brokers does not make any representations or warranties concerning the services offered, their past or future performance, or the accuracy of the information provided by the third party. Past performance is no guarantee of future results.

This material is from ISS EVA and is being posted with its permission. The views expressed in this material are solely those of the author and/or ISS EVA and Interactive Brokers is not endorsing or recommending any investment or trading discussed in the material. This material is not and should not be construed as an offer to buy or sell any security. It should not be construed as research or investment advice or a recommendation to buy, sell or hold any security or commodity. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

IBKR Campus Newsletters

This website uses cookies to collect usage information in order to offer a better browsing experience. By browsing this site or by clicking on the "ACCEPT COOKIES" button you accept our Cookie Policy.